Log In
Print
BCIQ
Print
Print this Print this
 

RG7795 (formerly ANA773)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionOral prodrug of toll-like receptor 7 (TLR7) agonist
Molecular Target Toll-like receptor 7 (TLR7)
Mechanism of ActionToll-like receptor 7 (TLR7) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat Hepatitis B virus (HBV) infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$230.0M

$230.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today